Replies to post #9248 on ANI Pharmaceuticals (ANIP)

[rgshredder]

jeffqdhsr, Art told me the same thing- very specifically said they wouldn't move forward on it without a partner-and there wasn't anyone interested in partnering or buying it from them at that time. I was surprised by his honesty. The way he made it sound, it was an asset associated with the merger but required more investment than he was willing to make. My conversation was a few years back as well.

From what I understand, I don't believe they've taken any steps forward on it. I tried reaching back out to him last December but always found my way to investor relations who simply referred me back to their website for answers to my questions. I recall them flat out refusing to answer any questions on libigel specifically, I took that as a positive given his openness ealier.

Congrats everyone, long time coming is an understatement.
-RG

[Just the facts maam]

Jeff, I agree that Corti is their main present focus.

If Libigel is viable as a future venture, the Corti operating income may be used fund ANIP's commitment to the partnership, allowing them to take larger stake in the partnership without diluting to raise capital.